Vfend and Cytoxan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vfend (voriconazole) and Cytoxan (cyclophosphamide). Common drug interactions include pyrexia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Vfend and Cytoxan. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Vfend?

Vfend has active ingredients of voriconazole. It is often used in aspergillosis. eHealthMe is studying from 12,128 Vfend users. Check the latest studies of Vfend.

What is Cytoxan?

Cytoxan has active ingredients of cyclophosphamide. It is often used in breast cancer. eHealthMe is studying from 19,693 Cytoxan users. Check the latest studies of Cytoxan.



On Jul, 19, 2026

23 people who take Vfend and Cytoxan together, and have interactions are studied.

Vfend and Cytoxan drug interactions.

What are the common drug interactions of Vfend and Cytoxan, by gender? *:

female:

  1. Pyrexia (fever)
  2. Dysuria (painful or difficult urination)
  3. Haematuria (presence of blood in urine)
  4. Micturition urgency (urgency to pass the urine)
  5. Cystitis viral (inflammation of the wall of the bladder by virus)
  6. Discomfort
  7. Neuropathy peripheral (surface nerve damage)
  8. Polyomavirus test positive
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Sinus congestion (blockage of sinus)

male:

  1. Pyrexia (fever)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Blood glucose increased
  4. Blood lactate dehydrogenase increased
  5. Blood phosphorus decreased
  6. Blood potassium decreased
  7. Blood triglycerides increased
  8. Carbon dioxide decreased
  9. Haematocrit decreased
  10. Liver injury

What are the common drug interactions of Vfend and Cytoxan, by age (0-1 to 60+)? *:

0-1:

  1. Abdominal infection
  2. Activated partial thromboplastin time prolonged
  3. Alanine aminotransferase increased
  4. Ammonia decreased
  5. Anion gap increased
  6. Aspartate aminotransferase increased
  7. Blast cell count increased
  8. Blood albumin decreased
  9. Blood calcium decreased
  10. Blood chloride increased

2-9:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Glucose urine present
  3. Pneumonia fungal
  4. Skin disorder (skin disease)

10-19:

  1. Chest discomfort
  2. Clonus (series of involuntary, rhythmic, muscular contractions and relaxations)
  3. Coagulopathy (blood's ability to clot is impaired)
  4. Confusional state
  5. Cough
  6. Delirium (wild excitement)
  7. Diarrhoea
  8. Dyspnoea (difficult or laboured respiration)
  9. Electrocardiogram qt prolonged
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

20-29:

  1. Hepatobiliary disease (diseases affect the liver and/or biliary tract)

30-39:

n/a

40-49:

n/a

50-59:

  1. Pyrexia (fever)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Dysuria (painful or difficult urination)
  4. Fatigue (feeling of tiredness)
  5. Haematuria (presence of blood in urine)
  6. Haemorrhage urinary tract (bleeding from uterine)
  7. Influenza
  8. Micturition urgency (urgency to pass the urine)
  9. Oedema peripheral (superficial swelling)
  10. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

60+:

  1. Pyrexia (fever)
  2. Angina pectoris (chest pain due to ischemia of the heart muscle)
  3. Haematemesis (vomiting of blood)
  4. Haematochezia (passage of stools containing blood)
  5. Haematuria (presence of blood in urine)
  6. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  7. Headache (pain in head)
  8. Hyperhidrosis (abnormally increased sweating)
  9. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  10. Melaena (the passage of black, tarry stools)

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 21.74%
  2. Bone Marrow Conditioning Regimen: 4 people, 17.39%
  3. Nausea (feeling of having an urge to vomit): 4 people, 17.39%
  4. Fungal Infection: 4 people, 17.39%
  5. White Blood Cell Disorder: 2 people, 8.70%
  6. High Blood Cholesterol: 2 people, 8.70%
  7. Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 2 people, 8.70%
  8. Constipation: 2 people, 8.70%
  9. Dehydration (dryness resulting from the removal of water): 2 people, 8.70%
  10. Depression: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Vfend and Cytoxan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vfend and Cytoxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vfend:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cytoxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vfend and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytoxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on voriconazole and cyclophosphamide (the active ingredients of Vfend and Cytoxan, respectively), and Vfend and Cytoxan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: